Focus Partners Wealth
RDY icon

Focus Partners Wealth’s Dr. Reddy's Laboratories RDY Stock Holding History

Focus Partners Wealth’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$448K Buy
30,898
+8,742
+39% +$118K ﹤0.01% 2021
2026
Q1 		$307K Buy
22,156
+6,623
+43% +$92.2K ﹤0.01% 2185
2025
Q4 		$218K Buy
15,533
+2,079
+15% +$29.2K ﹤0.01% 2406
2025
Q3 		$200K Sell
13,454
-10,306
-43% -$148K ﹤0.01% 2063
2025
Q2 		$357K Buy
23,760
+12,490
+111% +$178K ﹤0.01% 1593
2025
Q1 		$149K Sell
11,270
-3,544
-24% -$48.9K ﹤0.01% 1784
2024
Q4 		$234K Buy
+14,814
New +$223K ﹤0.01% 1664

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Focus Partners Wealth's RDY Position: Q2 2026 in Review

Focus Partners Wealth increased its Dr. Reddy's Laboratories (RDY) stake by 39% in Q2 2026, buying an estimated $118K and bringing the position to 30,898 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #2021.

Focus Partners Wealth first reported a position in RDY in Q4 2024 and has held it in 7 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Focus Partners Wealth held 30,898 shares of Dr. Reddy's Laboratories worth $448K as of Q2 2026.
  • Focus Partners Wealth bought 8,742 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $118K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2021 holding.
  • Focus Partners Wealth first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 7 quarters since.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.